Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (121-130 of 308) with videos related to

Pageof 31
Sort By:
Pharmacoepidemiology and Drug Safety|August 2, 2011
Measuring balance and model selection in propensity score methodsSvetlana V Belitser, Edwin P Martens, Wiebe R Pestman, et al.
Frontiers in Oncology|January 6, 2022
Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan DesignationJorn Mulder, Tobias van Rossum, Segundo Mariz, et al.
Journal of Pharmaceutical Policy and Practice|January 9, 2026
Factors influencing pharmaceutical companies' decisions to pursue compassionate use programs in the EU: a qualitative study in The NetherlandsAimée Timmerman, Nienke Rodenhuis, Lucia Marie Albertine Crane-van Opstal, et al.
Pharmacoepidemiology and Drug Safety|January 8, 2025
Multiple Perspectives on the Need for Real-World Evidence to Inform Regulatory and Health Technology Assessment Decision-Making: Scoping Review and Stakeholder InterviewsMarieke S Jansen, Olaf M Dekkers, Saskia le Cessie, et al.
Health and Quality of Life Outcomes|December 1, 2018
Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility studyAmr Makady, Rachel R J Kalf, Bettina Ryll, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Pharmacogenetics of cardiovascular drug therapyBas J M Peters, Olaf H Klungel, Anthonius de Boer, et al.
Pharmacogenomics|December 17, 2015
Seventeen years of statin pharmacogenetics: a systematic reviewMaarten Leusink, N Charlotte Onland-Moret, Paul I W de Bakker, et al.
Pharmacoeconomics|December 8, 2017
Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA AgenciesAmr Makady, Ard van Veelen, Páll Jonsson, et al.
Bone|June 27, 2013
Five-year fracture risk estimation in patients with Parkinson's diseaseSander Pouwels, Marloes T Bazelier, Anthonius de Boer, et al.
American Journal of Hypertension|February 28, 2009
Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diureticsOzlem Bozkurt, Anthonius de Boer, Diederik E Grobbee, et al.
Pageof 31

Showing results (121-130 of 308) with videos related to

Sort By:
Pageof 31
Pharmacoepidemiology and Drug Safety|August 2, 2011
Measuring balance and model selection in propensity score methodsSvetlana V Belitser, Edwin P Martens, Wiebe R Pestman, et al.
Frontiers in Oncology|January 6, 2022
Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan DesignationJorn Mulder, Tobias van Rossum, Segundo Mariz, et al.
Journal of Pharmaceutical Policy and Practice|January 9, 2026
Factors influencing pharmaceutical companies' decisions to pursue compassionate use programs in the EU: a qualitative study in The NetherlandsAimée Timmerman, Nienke Rodenhuis, Lucia Marie Albertine Crane-van Opstal, et al.
Pharmacoepidemiology and Drug Safety|January 8, 2025
Multiple Perspectives on the Need for Real-World Evidence to Inform Regulatory and Health Technology Assessment Decision-Making: Scoping Review and Stakeholder InterviewsMarieke S Jansen, Olaf M Dekkers, Saskia le Cessie, et al.
Health and Quality of Life Outcomes|December 1, 2018
Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility studyAmr Makady, Rachel R J Kalf, Bettina Ryll, et al.
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Pharmacogenetics of cardiovascular drug therapyBas J M Peters, Olaf H Klungel, Anthonius de Boer, et al.
Pharmacogenomics|December 17, 2015
Seventeen years of statin pharmacogenetics: a systematic reviewMaarten Leusink, N Charlotte Onland-Moret, Paul I W de Bakker, et al.
Pharmacoeconomics|December 8, 2017
Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA AgenciesAmr Makady, Ard van Veelen, Páll Jonsson, et al.
Bone|June 27, 2013
Five-year fracture risk estimation in patients with Parkinson's diseaseSander Pouwels, Marloes T Bazelier, Anthonius de Boer, et al.
American Journal of Hypertension|February 28, 2009
Variation in Renin-Angiotensin system and salt-sensitivity genes and the risk of diabetes mellitus associated with the use of thiazide diureticsOzlem Bozkurt, Anthonius de Boer, Diederik E Grobbee, et al.
Pageof 31